drugset / Trial / NCT03240523
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to describe the efficacy of vilaprisan in subjects with uterine fibroids compared to ulipristal. The secondary objective of this study is to evaluate the efficacy and safety of different treatment regimens of vilaprisan in subjects with uterine fibroids.
Timeline
- Start
- 2017-07-31
- Primary completion
- 2020-06-28
- Completion
- 2021-10-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vilaprisan | Other / unclassified | 2 mg | Oral |